157 related articles for article (PubMed ID: 33560220)
1. Unusual ischemic kidney injury presenting as slowly declining graft function and successful use of oral desmopressin in a kidney transplant recipient with subclinical central diabetes insipidus.
Kaneko S; Usui J; Kawanishi K; Ishii R; Takahashi K; Suzuki H; Saito C; Oda T; Nagata M; Yamagata K
Clin Nephrol; 2021 Apr; 95(4):208-214. PubMed ID: 33560220
[TBL] [Abstract][Full Text] [Related]
2. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
4. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
5. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
6. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
Biset A; Claris O
Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
[TBL] [Abstract][Full Text] [Related]
8. Transient polyuria related to central diabetes insipidus caused by lymphocytic infundibulo-neurohypophysitis in a patient treated for Graves' disease.
Yamazaki M; Sato A; Nishio S; Uehara T; Komatsu M
Intern Med; 2010; 49(17):1885-90. PubMed ID: 20823651
[TBL] [Abstract][Full Text] [Related]
9. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
10. Permanent central diabetes insipidus after traumatic brain injury. Case report and literature review.
Astafyeva LI; Sidneva YG; Badmaeva IN; Kalinin PL; Latyshev YA; Marshintsev AV; Valiullina SA
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):112-118. PubMed ID: 36252201
[TBL] [Abstract][Full Text] [Related]
11. The influence of vasopressin deficiency and acute desmopressin administration on melatonin secretion in patients with central diabetes insipidus.
Catrina SB; Rotarus R; Wivall IL; Coculescu M; Brismar K
J Endocrinol Invest; 2004 Jan; 27(1):47-51. PubMed ID: 15053243
[TBL] [Abstract][Full Text] [Related]
12. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
Kim F; Towers HM
J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
[TBL] [Abstract][Full Text] [Related]
13. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
14. [Central diabetes insipidus: diagnosis and management].
Ballan BK; Hernandez A; Rodriguez EG; Meyer P
Rev Med Suisse; 2012 Nov; 8(362):2158, 2160-4. PubMed ID: 23240316
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
16. Management of central diabetes insipidus.
Garrahy A; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
[TBL] [Abstract][Full Text] [Related]
17. Central diabetes insipidus with anti-rabphilin-3A antibody positivity causing hypovolemic shock after resection of tumorous lesions in the pelvic cavity.
Ohashi A; Takeda Y; Watada M; Ihara F; Oshita T; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Maeda Y
CEN Case Rep; 2023 Aug; 12(3):297-303. PubMed ID: 36574196
[TBL] [Abstract][Full Text] [Related]
18. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Central Diabetes Insipidus in Adults.
Tomkins M; Lawless S; Martin-Grace J; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2022 Sep; 107(10):2701-2715. PubMed ID: 35771962
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]